✨ Medicines Act Notices




NEW ZEALAND GAZETTE

18 DECEMBER

Medicines Act 1981

Corrigendum

In the notice published in the New Zealand Gazette, 30 October 1997, No. 155, page 3661, notice No. 7773, replace the entry with the following (the difference between this notice and the previous notice is the inclusion of the prescribing information):

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Warfarin sodium 1 mg, 2 mg, 5 mg Tablets The Boots Company PLC., Nottingham, United Kingdom Coumadin

Note: This consent is valid for 2 years from 31 October 1997.

This medicine may only be distributed, supplied or used under the following conditions:

  1. The product is not to be marketed as substitutable for Marevan as if the two (2) products were bioequivalent; and
  2. Prescribers are to be advised that when starting on Coumadin the dosage for each patient should be individually titrated according to therapeutic response determined by monitoring appropriate coagulation parameter.

Dated this 15th day of December 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go9166

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Disodium clodronate 520 mg Tablet, film coated Boehringer Mannheim GmbH., Mannheim, Germany Ostac
Disodium clodronate 400 mg Capsule Boehringer Mannheim GmbH., Mannheim, Germany Ostac

Dated this 12th day of December 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go9157

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Tolcapone 100 mg, 200 mg Tablet, film coated F Hoffmann-La Roche Limited, Basle, Switzerland Tasmar

Dated this 8th day of December 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go9158



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1997, No 178


NZLII PDF NZ Gazette 1997, No 178





✨ LLM interpretation of page content

πŸ₯ Corrigendum to Renewal of Provisional Consent for Warfarin Sodium

πŸ₯ Health & Social Welfare
15 December 1997
Medicines Act 1981, Corrigendum, Warfarin sodium, Coumadin, Provisional consent
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Consent to Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
12 December 1997
Medicines Act 1981, Disodium clodronate, Ostac, Changed medicines
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Consent to Distribution of New Medicine Tolcapone

πŸ₯ Health & Social Welfare
8 December 1997
Medicines Act 1981, Tolcapone, Tasmar, New medicine
  • G. R. Boyd, Chief Advisor, Regulation and Safety